Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-176545
Filing Date
2020-06-23
Accepted
2020-06-23 16:21:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d938512dsc13ga.htm SC 13G/A 39645
  Complete submission text file 0001193125-20-176545.txt   41146
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88552 | Film No.: 20982121
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 GRESHAM STREET LONDON X0 EC2V 7NQ
Business Address 65 GRESHAM STREET LONDON X0 EC2V 7NQ 44 (0)20 7954 9710
Link Fund Solutions Ltd (Filed by) CIK: 0001792424 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A